Wednesday, August 28, 2019

Tetrahydrabiopterin effective autism relief treatment....Sapropterin

Tetrahydrobiopterin (BH4, THB), also known as sapropterin, is a naturally occurring essential cofactor of the three aromatic amino acid hydroxylase enzymes, used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), melatonin, dopamine, norepinephrine (noradrenaline), epinephrine (adrenaline), and is a cofactor for the production of nitric oxide (NO) by the nitric oxide synthases. Chemically, its structure is that of a reduced pteridine derivative. Phenylketonuria Sapropterin dihydrochloride may help lower phenylalanine levels in some people with phenylketonuria. It is FDA approved for this use along with dietary measures. Most people however, have little or no benefit. Tetrahydrobiopterin has the following responsibilities as a cofactor: Tryptophan hydroxylase (TPH) for the conversion of L-tryptophan (TRP) to 5-hydroxytryptophan (5-HTP) Phenylalanine hydroxylase (PAH) for conversion of L-phenylalanine (PHE) to L-tyrosine (TYR) Tyrosine hydroxylase (TH) for the conversion of L-tyrosine to L-DOPA (DOPA) Nitric oxide synthase (NOS) for conversion of a guanidino nitrogen of L-arginine (L-Arg) to nitric oxide (NO) Alkylglycerol monooxygenase (AGMO) for the conversion of 1-alkyl-sn-glycerol to 1-hydroxyalkyl-sn-glycerol BH4 also serves as a catalyst for the production of nitric oxide. Among other things, nitric oxide is involved in vasodilation, which improves systematic blood flow. The role of BH4 in this enzymatic process is so critical that some research points to a deficiency of BH4 – and thus, of nitric oxide – as being a core cause of the neurovascular dysfunction that is the hallmark of circulation-related diseases such as diabetes. Other than PKU studies, tetrahydrobiopterin has participated in clinical trials studying other approaches to solving conditions resultant from a deficiency of tetrahydrobiopterin. These include autism, ADHD, hypertension, endothelial dysfunction, and chronic kidney disease.

Sapropterin therapy: sapropterin is a synthetic form of cofactor BH4 and is able to partially restore PAH activity or supply BH4, thereby decreasing the amounts of phenylalanine and phenylketone and increasing tyrosine (and dopamine) production


What Decreases BH4?

  • Heavy metals such as MercuryLeadAluminum and Iron R
  • High protein diet R R
  • Hydrogen peroxide R
  • Hyperammonia R
  • Inflammation R R R R
  • Methotrexate, which inhibits DHFR R
  • Oxidative Stress/Damage R R  R
  • Peroxynitrite R
  • Sun/UV R
  • The mutations listed above R

Mechanism Of Action

Intracellular 5,6,7,8-tetrahydrobiopterin (BH  4  ), synthesis, oxidation, and recycling in endothelial cells. GTP, guanidine triphosphate; GTPCHI, GTP cyclohydrolase I; PTPS, pyruvoyl tetrahydrobiopterin synthase; SR, sepiapterin reductase; DHFR, dihydrofolate reductase; ˙NO, nitric oxide; O  2  ·−  , superoxide anion radical; ONOO  −  , peroxynitrite; H  2  0  2  , hydrogen peroxide; BH  3  ˙  ,   trihydrobiopterin radical; DHF, dihydrofolate; 5MTHF, 5-methyltetrahydofolate; eNOS, endothelial nitric oxide synthase; Asc, ascorbate; Asc˙−, ascorbate radical.
Intracellular 5,6,7,8-tetrahydrobiopterin (BH4), synthesis, oxidation, and recycling in endothelial cells. GTP, guanidine triphosphate; GTPCHI, GTP cyclohydrolase I; PTPS, pyruvoyl tetrahydrobiopterin synthase; SR, sepiapterin reductase; DHFR, dihydrofolate reductase; ˙NO, nitric oxide; O2·−, superoxide anion radical; ONOO, peroxynitrite; H202, hydrogen peroxide; BH3˙, trihydrobiopterin radical; DHF, dihydrofolate; 5MTHF, 5-methyltetrahydofolate; eNOS, endothelial nitric oxide synthase; Asc, ascorbate; Asc˙−, ascorbate radical.
Here is a summary of the BH4-related biochemical transformations: R
  • Phenylalanine hydroxylase (PAH) enzyme to convert Phenylalanine (PHE) to Tyrosine (TYR)
  • Tyrosine hydroxylase (TH) enzyme to convert Tyrosine to L-DOPA (DOPA)
  • Tryptophan hydroxylase (TPH) enzyme to convert Tryptophan to 5-Hydroxytryptophan (5-HTP)
  • Nitric oxide synthase (NOS) enzyme to convert a Arginine (ARG) to Nitric oxide (NO)
The enzyme DHFR may recycle BH2 into BH4.
This would be after exogenously administered BH4 has been oxidized into BH2. R

Nitric Oxide Production

BH4 is important for nitric oxide synthases and when it is missing, enzymes become "uncoupled". This uncoupling produces Reactive Oxygen Species (ROS) rather than NO. 

Genetics For Low BH4

If your parents are heterozygous, you have a  1-in-4 chance.
If your parents are heterozygous, you have a 1-in-4 chance.
Defects in these genes can predispose you to low BH4 production.
  • MTHFR A1298C (rs1801131) is involved in converting 5-methylfolate (5MTHF) to tetrahydrofolate (THF). A1298C helps generate BH4. R
  • CBS catalyzes the first step of the transsulfuration pathway, from homocysteine to cystathionine. BH4 can also become depleted with a CBS upregulation. R
  • DHFR encodes an enzyme that plays a part in folate metabolism. R R
  • GCH1 encodes an enzyme called GTP cyclohydrolase 1. It helps produce BH4. R
  • SPR provides instructions for making the sepiapterin reductase enzyme, which is involved in the last of three steps of producing BH4. R
  • GCHFR binds to and mediates tetrahydrobiopterin inhibition of GTP cyclohydrolase I. R
  • PTS facilitates folate biosynthesis. A mutation in this gene could directly cause BH4 deficiency. R
  • QDPR produces the enzyme quinoid dihydropteridine reductase. This enzyme is part of the pathway that recycles BH4. R

Biosynthesis For Low BH4

GTP (guanosine triphosphate) converts into dihydroneopterin tiphosphate (GCH1 gene).
Dihydroneopterin triphosphate and magnesium convert into 6-pyruvoyl-tetrahydropterin vita (PTS gene).
Dihydroneopterin triphosphate can degrade into neopterin. 
6-pyruvoyl-tetrahydropterin and NADPH convert into BH4 and NADP (SPR gene).
6-pyruvoyl-tetrahydropterin can also degrade to sepiapterin and then BH2. 
BH2 and folate convert to BH4 (DHFR gene). 
GCHFR can be a feedback mechanism for GCH1 activity.
GCHFR will inhibit GCH1, but if phenylalanine is present, it will stimulate GCH1.

Ways To Increase Tyrosine Hydroxylase

My Top 5 Ways To Increase TH

  1. Bright Light Device (or I'll use Sunlight and Blue Light)
  2. Butyrate R
  3. Exercise R
  4. Music - this is what I listen to R
  5. Uridine + Eating Fish (or fish oilR

Diet / Lifestyle / Devices:

Supplements:

Hormones:

  • Insulin R
  • Melatonin (increases it in ventral mesencephalon but not in the hypothalamus) R R
  • Oxytocin (coexpressed in the hypothalamus) R
  • Vitamin D (D3) R R R

Drugs/Chemicals:

  • Alcohol (acutely and decreases with alcohol tolerance) R R
  • Amphetamines R
  • BH4 (tetrahydrobiopterin) R
  • Bradykinin R
  • Bromantane (Lodastan) R R R
  • Carbachol R
  • Ceftriaxone R
  • Cilostazol R
  • Cocaine (decreases w/ tolerance) R
  • Deferoxamine R R
  • Dexamethasone R
  • Fluoxetine R R
  • Hydrocortisone R
  • Intranasal Testosterone Propionate R
  • Nicotine R
  • Nomifensine R
  • Perindopril R

Pathways:

  • Acetylcholine R
  • α-Synuclein inhibition R
  • BDNF R R
  • cAMP (PKA) R R
  • CB1 (increases TH activity) R
  • CB2 (protects TH neurons) R
  • CDNF R R
  • EGF R
  • ERK R
  • FoxO1 inhibition (activation lowers activity) R
  • GDNF (dose dependent) R
  • HIF1alpha R
  • Hsc70 R
  • Increase Tregs cells R
  • Laminin R
  • MANF R
  • M1 mAChR R
  • nAChR R
  • NGF R R
  • Nitric Oxide R
  • Noggin R
  • NRF2 (protective of TH neurons) R
  • NR4A2 (downstream increases TH, VMAT2, and DAT) R
  • PARK7/DJ-1 R
  • PDE2 inhibition R
  • PPAR-γ R
  • ser40 R
  • TGF-B1 R

Other:

  • Butterfly Bush R
  • Silver (during pregnancy may increase TH in offspring) R

What Reduces Tyrosine Hydroxylase?

Lifestyle:

  • Intermittent hypoxia training R
  • Oxidative Stresss (ie N2O, OONO) R
  • Sleep Deprivation R

Devices:

  • Deep Brain Stimulation (reduced activity in the PFC) R

Supplements:

Hormones:

  • Estrogen (E2, but ER-alpha increases TH during pregnancy/lactation) R R
  • Prolactin R

Drugs/Chemicals:

  • Alpha-methyl-p-tyrosine (AMPT) and and iodotyrosines R
  • Ketamine R
  • PrPC R
  • Rhynchophylline R

Pathways:

  • Amyloid Beta R
  • GABA (in eye) R
  • GSK-3β R
  • Negative feedback - Dopamine , L Dopa, Norepinephrine, Phenylalanine, AMPT (above) R R